These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22321711)

  • 1. [Analysis of the antimycobacterial activities of rifabutin and the relationship between drug-resistance and rpoB mutations of Mycobacterium tuberculosis].
    Han XQ; Huang HR; Li YJ; Yu X; Gao JT; Bi ZQ; Chu NH; Li L; Ma Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Oct; 34(10):762-5. PubMed ID: 22321711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cross-resistance between rifampicin and rifabutin among multi-drug resistant Mycobacterium tuberculosis strains].
    Chikamatsu K; Mizuno K; Yamada H; Mitarai S
    Kekkaku; 2009 Sep; 84(9):631-3. PubMed ID: 19860266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
    Cavusoglu C; Karaca-Derici Y; Bilgic A
    Clin Microbiol Infect; 2004 Jul; 10(7):662-5. PubMed ID: 15214882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis.
    Yang B; Koga H; Ohno H; Ogawa K; Fukuda M; Hirakata Y; Maesaki S; Tomono K; Tashiro T; Kohno S
    J Antimicrob Chemother; 1998 Nov; 42(5):621-8. PubMed ID: 9848446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations.
    ElMaraachli W; Slater M; Berrada ZL; Lin SY; Catanzaro A; Desmond E; Rodrigues C; Victor TC; Crudu V; Gler MT; Rodwell TC
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1222-6. PubMed ID: 26459537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The studies on the molecular mechanism of rifampin-resistant Mycobacterium tuberculosis].
    Zhuang Y; He X; Zhang X
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Dec; 23(12):711-4. PubMed ID: 11778472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany.
    Glocker E; Bogdan C; Kist M
    J Antimicrob Chemother; 2007 May; 59(5):874-9. PubMed ID: 17350989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampin-resistance-associated mutations in the rifampin-resistance-determining region of the
    Guo Y; Cao X; Yang J; Wu X; Liu Y; Wan B; Hu L; Wang H; Yu F
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33507146
    [No Abstract]   [Full Text] [Related]  

  • 9. Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?
    Schön T; Juréen P; Chryssanthou E; Giske CG; Kahlmeter G; Hoffner S; Angeby K
    J Antimicrob Chemother; 2013 Sep; 68(9):2074-7. PubMed ID: 23633684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis.
    Kurabachew M; Lu SH; Krastel P; Schmitt EK; Suresh BL; Goh A; Knox JE; Ma NL; Jiricek J; Beer D; Cynamon M; Petersen F; Dartois V; Keller T; Dick T; Sambandamurthy VK
    J Antimicrob Chemother; 2008 Oct; 62(4):713-9. PubMed ID: 18587134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.
    Kozhamkulov U; Akhmetova A; Rakhimova S; Belova E; Alenova A; Bismilda V; Chingissova L; Ismailov S; Ramanculov E; Momynaliev K
    Jpn J Infect Dis; 2011; 64(3):253-5. PubMed ID: 21617314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characterization of rpoB mutation in rifampin - resistant clinical Mycobacterium tuberculosis isolates from China].
    Huang H; Jin Q; Ma Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Apr; 24(4):231-5. PubMed ID: 11802970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis].
    Sato K; Tomioka H; Saito H; Kawahara S; Hidaka T
    Kekkaku; 1996 Aug; 71(8):459-64. PubMed ID: 8831191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency.
    Anthony RM; Schuitema AR; Bergval IL; Brown TJ; Oskam L; Klatser PR
    Ann Clin Microbiol Antimicrob; 2005 Jun; 4():9. PubMed ID: 15958167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cross-resistance between rifampin and rifabutin in multidrug resistant Mycobacterium tuberculosis complex strains].
    Gao L; Xiao HP; Hu ZY; Cui ZL; Lu JM; Shen XN
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 May; 35(5):333-5. PubMed ID: 22883990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-resistance between rifampicin and KRM-1648 is associated with specific rpoB alleles in Mycobacterium tuberculosis.
    Park YK; Kim BJ; Ryu S; Kook YH; Choe YK; Bai GH; Kim SJ
    Int J Tuberc Lung Dis; 2002 Feb; 6(2):166-70. PubMed ID: 11931418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis using denaturing gradient gel electrophoresis.
    McCammon MT; Gillette JS; Thomas DP; Ramaswamy SV; Graviss EA; Kreiswirth BN; Vijg J; Quitugua TN
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2200-9. PubMed ID: 15917513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis clinical isolates.
    Wu X; Zhang J; Zhuang Y; Zhang X; Li G; He X
    Chin Med J (Engl); 1999 Jun; 112(6):524-8. PubMed ID: 11601331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates.
    Soudani A; Hadjfredj S; Zribi M; Masmoudi A; Messaoud T; Tiouri H; Fendri C
    J Clin Microbiol; 2007 Sep; 45(9):3095-7. PubMed ID: 17652484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil.
    Höfling CC; Pavan EM; Giampaglia CM; Ferrazoli L; Aily DC; de Albuquerque DM; Ramos MC
    Int J Tuberc Lung Dis; 2005 Jan; 9(1):87-93. PubMed ID: 15675556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.